A fatal case of acute interstitial pneumonia (AIP) in a woman affected by glioblastoma

Current Drug Safety

Volumn 9, Issue 1, 2014, Pages 73-76

  Balzarini, Laura ^a   Mancini, Chiara ^a   Marvisi, Maurizio ^a  

^a Istituto Figlie di S Camillo   (Italy)

Author keywords

Acute interstitial pneumonia; Desquamative pneumonitis; Drugs induced lung disease; Temozolamide

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; COTRIMOXAZOLE; LACTATE DEHYDROGENASE; TEMOZOLOMIDE;

AGED; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CULTURE; BRONCHOSCOPY; CANCER ADJUVANT THERAPY; CASE REPORT; CHEMOPROPHYLAXIS; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; FATALITY; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HYPOCAPNIA; HYPOXEMIA; INTERSTITIAL PNEUMONIA; LEUKOCYTE COUNT; LUNG AUSCULTATION; LUNG BIOPSY; LUNG LAVAGE; PERIPHERAL EDEMA; PHYSICAL EXAMINATION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; TRANSBRONCHIAL BIOPSY; URINE SEDIMENT; WEAKNESS;

AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BLOOD GAS ANALYSIS; BRAIN NEOPLASMS; BRONCHOALVEOLAR LAVAGE FLUID; DACARBAZINE; ELECTROCARDIOGRAPHY; FATAL OUTCOME; FEMALE; GLIOBLASTOMA; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; PHYSICAL EXAMINATION; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 84895421817     PISSN: 15748863     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574886308666140106154343     Document Type: Article

References (12)

1. Supp R, Mason WP, Van Den BMJ, et al. Radio therapy plus concomitant and adjuvant temozolamide for glioblastoma. N Engl J Med 2005; 352: 987-96.
2. Marcus N, Christian B, Fleckenstein J, et al. Toxicity after radiochemotherapy for glioblastoma using temozolamide a retrospective evaluation. Radiat Oncol 2011; 6: 141.
3. Brandes AA, Tosoni A, Cavallo G, et al. Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperative di neuro-oncologia (GICNO). Br J Cancer 2006; 95: 1155-60.
4. Yu SK, Chalmers AJ. Patients receiving standard-dose temozolomide therapy are at risk of Pneumocystis carinii pneumonia. Clin Oncol (R Coll Radiol) 2007; 19(8): 631-2.
5. Hiroki H, Yoshinobu S, et al. Fatal Pneumonia Associated with Temozolomide Therapy in Patients with Malignant Glioma. Jpn J Clin Oncol 2012; 42(7): 632-6.
6. Maldonado F, Limper AH, et al. Temozolmide-associated organizing pneumonitis. Mayo Clinc Proc 2007; 82: 771-3.
7. Guilleminault L, Carré P, de Luca K, et al. Alveolo-interstitial pneumonia due to Temozolamide. Rev Mal Respir 2008; 25(7): 880-4.
8. Tae-Ok K, In-Jae O, et al. Temozolomide-Associated Bronchiolitis Obliterans Organizing Pneumonia Successfully Treated with High-Dose Corticosteroid. J Korean Med Sci 2012; 27: 450-3.
9. Koschel D, Handzhiev S, et al. Hypersensitivity pneumonitis associated with the use of temozolomide. Eur Respir J 2009; 33: 931-4.
10. Higgins T, Niklasson PM. Hypersensitivity Pneumonitis induced by trimethoprim. BMJ 1990; 300: 1344.
11. N. Oshitani, Matsumot T, Moriyamay Y. Drug induced pneimonitis caused by sulfamethoxazole-trimethoprim during treatment of pneumocistis carinii pneumoniae in patient with refractory ulcerative colitis. J Gastroenterol 1998; 33: 578-81.
12. Silvestri RC, Jensen WA, Zibrakki JD, et al. Pulmonary infiltrates and hypoxemia in patients with acquired immunodeficiency syndrome re-exposed to trimethoprim-sulfamethoxazole. Am Rev Respir Dis 1987; 136: 1003-4.